Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Susan Scanland

Nurse Practitioner, Gerontology Scranton, PA Nurse Practitioner

NPI 1740242064 CMS profile 11066568

501 S Washington Ave Ste 1000, Scranton, PA 18505

Open in the dashboard

General payments

$516,869

648 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Susan Scanland of Scranton, PA is reported in the CMS Open Payments database as having received $516,869 across 648 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Gerontology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $45,052 48
2024 General $121,058 154
2023 General $111,171 157
2022 General $175,386 213
2021 General $64,201 76

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Susan Scanland
  • Nurse Practitioner, Gerontology median
  • Middle half of Nurse Practitioner, Gerontology
  • National median

In program year 2025, general payments to Susan Scanland were reported at $45,052. Among 4,139 Nurse Practitioner, Gerontology profiles paid that year, the median was $179 and the middle half received between $55 and $547.

Show as a table
Year Susan Scanland Nurse Practitioner, Gerontology median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $64,201 $133 $44–$396 $132
2022 $175,386 $142 $48–$452 $149
2023 $111,171 $158 $53–$482 $160
2024 $121,058 $171 $55–$533 $164
2025 $45,052 $179 $55–$547 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Teva Pharmaceuticals USA, Inc. $362,780 450 payments
  2. ACADIA Pharmaceuticals Inc $98,644 131 payments
  3. Otsuka America Pharmaceutical, Inc. $13,924 21 payments
  4. BioXcel Therapeutics, Inc. $12,950 2 payments
  5. Eisai Inc. $11,164 10 payments
  6. Axsome Therapeutics, Inc. $10,317 17 payments
  7. Lundbeck LLC $5,032 11 payments
  8. Genentech USA, Inc. $1,695 1 payment
  9. Alpha Cognition USA, Inc. $115 1 payment
  10. Biogen, Inc. $80 1 payment
  11. Other $169 3 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $354,912 154 payments
  2. Travel and Lodging $73,689 253 payments
  3. Consulting Fee $70,612 31 payments
  4. Food and Beverage $12,940 208 payments
  5. Honoraria $4,715 2 payments
Products named General payments · program years 2021–2025
  1. Austedo XR $200,748 260 payments
  2. AUSTEDO $162,032 190 payments
  3. NUPLAZID Parkinsons Disease Psychosis $89,749 123 payments
  4. REXULTI Psychiatry $13,974 22 payments
  5. IGALMI $12,950 2 payments
  6. Leqembi $6,090 4 payments
  7. REXULTI Psychiatry $5,032 11 payments
  8. NUPLAZID Parkinsons Disease Psychosis $4,182 5 payments
  9. Zunveyl Neurology $115 1 payment
  10. Zunveyl Neurology $115 1 payment
  11. Other $131 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

648 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record